Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with <i>SPG7</i>

Giulia Coarelli(Centre National de la Recherche Scientifique), Rebecca Schüle(Centre National de la Recherche Scientifique), Bart P.C. van de Warrenburg(Centre National de la Recherche Scientifique), Peter De Jonghe(Centre National de la Recherche Scientifique), Claire Ewenczyk(Centre National de la Recherche Scientifique), Andrea Martinuzzi(Centre National de la Recherche Scientifique), Matthis Synofzik(Centre National de la Recherche Scientifique), Elisa G. Hamer(Centre National de la Recherche Scientifique), Jonathan Baets(Centre National de la Recherche Scientifique), Mathieu Anheim(Centre National de la Recherche Scientifique), Lüdger Schöls(Centre National de la Recherche Scientifique), Tine Deconinck(Centre National de la Recherche Scientifique), Pegah Masrori(Centre National de la Recherche Scientifique), Bertrand Fontaine(Centre National de la Recherche Scientifique), Thomas Klockgether(Centre National de la Recherche Scientifique), Maria Grazia D’Angelo(Centre National de la Recherche Scientifique), Marie‐Lorraine Monin(Centre National de la Recherche Scientifique), Jan De Bleecker(Centre National de la Recherche Scientifique), Isabelle Migeotte(Centre National de la Recherche Scientifique), Perrine Charles(Centre National de la Recherche Scientifique), Maria Teresa Bassi(Centre National de la Recherche Scientifique), Thomas Klopstock(Centre National de la Recherche Scientifique), Fanny Mochel(Centre National de la Recherche Scientifique), Elisabeth Ollagnon‐Roman(Centre National de la Recherche Scientifique), Marc D’Hooghe(Centre National de la Recherche Scientifique), Christoph Kamm(Centre National de la Recherche Scientifique), Delia Kurzwelly(Centre National de la Recherche Scientifique), Mélanie Papin(Centre National de la Recherche Scientifique), Claire‐Sophie Davoine(Centre National de la Recherche Scientifique), Guillaume Banneau(Centre National de la Recherche Scientifique), Sophie Tézenas du Montcel(Centre National de la Recherche Scientifique), Danielle Seilhean(Centre National de la Recherche Scientifique), Alexis Brice(Centre National de la Recherche Scientifique), Charles Duyckaerts(Centre National de la Recherche Scientifique), Giovanni Stévanin(Centre National de la Recherche Scientifique), Alexandra Dürr(Centre National de la Recherche Scientifique)
Neurology
May 9, 2019
Cited by 61Open Access
Full Text

Abstract

<h3>Objective</h3> We took advantage of a large multinational recruitment to delineate genotype-phenotype correlations in a large, trans-European multicenter cohort of patients with spastic paraplegia gene 7 (<i>SPG7</i>). <h3>Methods</h3> We analyzed clinical and genetic data from 241 patients with <i>SPG7</i>, integrating neurologic follow-up data. One case was examined neuropathologically. <h3>Results</h3> Patients with <i>SPG7</i> had a mean age of 35.5 ± 14.3 years (n = 233) at onset and presented with spasticity (n = 89), ataxia (n = 74), or both (n = 45). At the first visit, patients with a longer disease duration (&gt;20 years, n = 62) showed more cerebellar dysarthria (<i>p</i> &lt; 0.05), deep sensory loss (<i>p</i> &lt; 0.01), muscle wasting (<i>p</i> &lt; 0.01), ophthalmoplegia (<i>p</i> &lt; 0.05), and sphincter dysfunction (<i>p</i> &lt; 0.05) than those with a shorter duration (&lt;10 years, n = 93). Progression, measured by Scale for the Assessment and Rating of Ataxia evaluations, showed a mean annual increase of 1.0 ± 1.4 points in a subgroup of 30 patients. Patients homozygous for loss of function (LOF) variants (n = 65) presented significantly more often with pyramidal signs (<i>p</i> &lt; 0.05), diminished visual acuity due to optic atrophy (<i>p</i> &lt; 0.0001), and deep sensory loss (<i>p</i> &lt; 0.0001) than those with at least 1 missense variant (n = 176). Patients with at least 1 Ala510Val variant (58%) were older (age 37.6 ± 13.7 vs 32.8 ± 14.6 years, <i>p</i> &lt; 0.05) and showed ataxia at onset (<i>p</i> &lt; 0.05). Neuropathologic examination revealed reduction of the pyramidal tract in the medulla oblongata and moderate loss of Purkinje cells and substantia nigra neurons. <h3>Conclusions</h3> This is the largest <i>SPG7</i> cohort study to date and shows a spasticity-predominant phenotype of LOF variants and more frequent cerebellar ataxia and later onset in patients carrying at least 1 Ala510Val variant.


Related Papers

No related papers found

Powered by citation graph analysis